) are thus both dispensable for growth on glucose, but the cell requires one or the other for growth on fructose. The two hexokinases are not functionally interchangeable, however, as there are differences in the phenotypes of null mutations in the two genes, notably in the growth rate on glucose and the degree of remaining glucose repression (47).
phenotypes in yeast strains bearing chromosomal hxkl and hxk2 null mutations. Some of these mutants were characterized both in vivo and in vitro; they displayed a wide spectrum of residual hexokinase activities, as indicated by three assays: in vitro enzyme activity, ability to grow on glucose and fructose, and ability to repress invertase production when growing on glucose. Of those that failed to support growth on fructose, only a small minority made normal-size, stable, and inactive protein. Analysis of the amino acid changes in these mutants in light of the crystallographically determined three-dimensional structure of hexokinase II suggests important roles in structure or catalysis for six amino acid residues, only two of which are near the active site.
Budding yeast (Saccharomyces cerevisiae) produces three different enzymes that can phosphorylate glucose and thus initiate glycolysis. Two of these (hexokinases I and II) phosphorylate fructose and mannose as well, allowing growth when either of these sugars is used as the sole source of carbon and energy; the third (glucokinase) phosphorylates only glucose and mannose (43, 44, 49, 50) . The two hexokinases (encoded by the HXKI and HXK2 genes [25, 28, 66] ) are thus both dispensable for growth on glucose, but the cell requires one or the other for growth on fructose. The two hexokinases are not functionally interchangeable, however, as there are differences in the phenotypes of null mutations in the two genes, notably in the growth rate on glucose and the degree of remaining glucose repression (47) . Yeast hexokinase isozymes have been the subject of a considerable number of biochemical studies (for reviews, see references 17 and 59) . The in vitro properties of the purified isoenzymes have been characterized previously (20) (21) (22) (69) (70) (71) . Chemical modification studies demonstrated that a thiol group (55) , a glutamyl residue (58) , and at least one arginyl residue (11, 57) are essential for the catalytic activity of yeast hexokinase; these residues have not been specifically identified. The pH dependence of hexokinase catalytic activity (72) indicates that an acidic group is crucial for catalysis, further supporting a role for a glutamyl residue in catalysis.
The yeast hexokinases have also been studied extensively by X-ray crystallography. The three-dimensional structures of the hexokinase II monomer in a complex with the glucose analog O-toluoylglucosamine (67) , its dimer without substrate (4) (5) (6) , and hexokinase I with glucose (8, 9) have been determined. Glucose binding induces a conformational change in both hexokinase isozymes from the open to the closed form (7, 51) . The structures of the enzymes have been refined (R. W. Harrison, Ph.D. dissertation, Yale University, New Haven, Conn., 1985) on the basis of X-ray diffraction data of 0.35-nm resolution for hexokinase I and 0.21-nm resolution for hexokinase II, using the amino acid sequences derived from the DNA sequences of HXKI and HXK2 (29, 39, 66) . The refined structures identify several residues that can form hydrogen bonds with the sugar (or analog) substrate and may be important for binding, catalysis, or both.
Hexokinase II is also necessary for cells to maintain normal glucose repression; it is necessary for regulation of genes for enzymes such as invertase. Both point mutations (23, 24) and null mutations (47) in HXK2 are known to block manifestation of glucose repression. Therefore, hexokinase II is a bifunctional protein, with effects in both glycolysis and glucose repression. It is not known, however, whether the involvement of hexokinase II in these two processes is mechanistically distinct. Point mutants of HXK2 have been found to cause defects in glucose repression yet still retain hexose phosphorylating activity (24) . These results led Entian and Frohlich to propose that hexokinase II has two domains, one for each function (24) .
This proposed structure of hexokinase II may be dissected with mutational analysis. If hexokinase II indeed has two domains, there should be mutations that lead to repressiondefective and catalysis-functional hexokinase II and also those that affect catalysis but not repression. Since relatively little is known about the functions of individual amino acid residues in catalysis or in glucose repression by hexokinase II, we have undertaken random mutagenesis of HXK2. Although a few residues potentially involved in substrate binding can be identified on the basis of the three-dimensional crystal structure, none of the residues involved in glucose repression are known. By using random mutagenesis and screening for various phenotypes, bias toward particular kinds of mutations or specific amino acid residues can be minimized.
In this paper, we describe the isolation, characterization, mapping, and sequencing of a large number of hxk2 mutations in the hope of revealing domains associated with a particular set of phenotypes. Our strategy was to induce the mutations in the cloned gene carried on a low-copy-number plasmid vector; to introduce the mutations into a hxkl hxk2 double-null yeast strain and screen for a defect in either growth or glucose repression; to place the mutations on a fine-structure map of the HXK2 gene; to analyze the phenotypes of a subset of particularly interesting mutations in vivo and in vitro; and to determine the DNA sequences of particularly interesting mutations.
The mutations we studied did not, in the end, provide evidence supporting a clear-cut domain structure separating the sugar-phosphorylating and glucose repression functions, although particular amino acid residues in the vicinity of the active site (as inferred from the crystal structure) are implicated in catalysis. The accompanying paper (46) reports a correlation between residual phosphorylation activity and residual glucose repression observed by using the mutations described here.
MATERUILS AND METHODS
Strains and plasmids. The yeast strains used are isogenic to S288C (MATa SUC2 gal2). The host strains for transformation are summarized in Table 1 ; the remaining strains are one or another of these host strains with a particular plasmid, usually carrying an allele of the HXK2 gene. Escherichia coli HB101 (13) was used for amplification of mutagenized DNA and individual plasmids. E. coli DB4729 [endA thi hsdR hsdM+ A(srlR-recA)306; from Barry Bochner] was used to obtain methylated DNA for transformation of E. coli DB6448. DB6448 (mutD5 rpsL aziR galU95; obtained from L. Enquist) was used to mutagenize pRB313. The mutD5 mutation (a dominant mutator) in DB6448 causes elevated frequency of spontaneous mutations, including transitions, transversions, and frameshift mutations (18, 19, 26) . Plasmid YEp420 has been described previously (48) . Plasmid pJJ101 (pRB529 [47] ) is a derivative of YIp5 (12) (Fig. 1) is a derivative of pBR328 with a 3.7-kb EcoRI fragment containing HXK2 (66) in the EcoRI site. Plasmid pT7-2 ( Fig. 2) was purchased from U.S. Biochemical Corp., Cleveland, Ohio (GeneScribe kit). Plasmid pSI4 (Fig. 3 [14] ) was a gift from Mark Johnson.
Plasmid construction. Several plasmids were constructed in vitro ( Fig. 1 to 3 ). Plasmid pRB1038 was constructed by using the method of homologous recombination of overlapping linear fragments in yeast cells (48) . A Ura-yeast strain was transformed with (i) a URA3-containing fragment from YIp5 by digestion with BamHI and PvuII and (ii) circular pJJ101; then the plasmid was recovered from Ura+ transformants. Plasmid pRB1167 was made in the same way by transforming a ura3-52 hxkl::LEU2 hxk2-202 strain with a mixture of (i) pRB976 carrying the hxk2-083 allele linearized by digesting with BglII and XhoI restriction endonucleases and (ii) a 2,um sequence-containing fragment generated from YEp420 by cutting with EcoRV, PstI, and SmaI restriction enzymes. The transformants were selected for growth on medium lacking uracil; the new plasmid, pRB1167, was recovered in E. coli HB101, and its structure was confirmed by restriction analysis. A derivative of pSI4 carrying hxk2-083 was constructed similarly by transforming yeast strain DBY2809 with a mixture of pRB701 (Fig. 3 ) linearized by cutting with SmaI enzyme and a 3.7-kb EcoRI fragment containing hxk2-083, selecting for Ura+ transformants.
Genetic and DNA manipulations and yeast transformation. Genetic manipulations in yeast cells were done as described previously (64) . Yeast cells were transformed by a modification (T. Steams, H. Ma, and D. Botstein, Methods Enzymol., in press) of the alkali cation method (38, 42) . Plasmids were recovered from yeast strains as described previously (37) . Sequencing was done directly from plasmid DNA by the double-strand procedure (34, 40) of the dideoxynucleotide termination method (63 Additional screens for mutants that are defective in glucose repression were performed by replica plating yeast transformants to media containing a combination of a sugar and a nonmetabolizable glucose analog, such as 2% galactose plus 0.1% glucosamine or 2% raffinose plus 0.1% glucosamine. Glucosamine has a repressive effect similar to that of glucose but cannot be further metabolized to yield energy (27) . Cells with a functional hexokinase II fail to grow on raffinose or galactose in the presence of glucosamine because synthesis of the enzymes needed for growth is repressed. Mutants that are defective in glucose repression should synthesize those enzymes and thus be able to utilize these carbon sources. Raffinose can be hydrolyzed relatively inefficiently by invertase to release fructose and melibiose. The latter is not used by the strains used in this study.
Therefore, cells need relatively high levels of invertase to hydrolyze enough raffinose for growth. Transformants were replica plated on glucosamine and either galactose or raffinose; those that showed better than wild-type growth were chosen as mutant candidates.
A screen for growth on raffinose and 2-deoxyglucose (73) was also used to select for hxk2 mutants that are defective in glucose repression and retain some phosphorylation activity. The rationale for plating on raffinose and 2-deoxyglucose is based on the fact that 2-deoxyglucose has a toxic effect that can be relieved by glucose or fructose. Mutants that fail to repress the SUC2 gene, a glucose repression-sensitive gene coding for invertase, will synthesize enough invertase for the hydrolysis of raffinose, thereby yielding fructose and relieving the toxicity of 2-deoxyglucose. If these mutants retain hexokinase activity, they can also use the fructose to support growth. The Ura+ yeast transformants were collected into pools and grown in liquid medium for 8 h or overnight on plates with 8% glucose; they were then plated on medium containing 2% raffinose and 0.02% 2-deoxyglucose, and colonies that grew were picked. This selection is not as stringent as we had hoped; sometimes mutants with very little hexokinase activity can still survive.
The phenotypes of the mutant candidates identified by these screens were rechecked. Plasmids were then recovered from those that retained their original phenotypes. The transformants with these newly isolated plasmids were then scored for the original phenotypes again. The Fine-structure deletion mapping. For the purpose of mapping the point mutations, deletions of HXK2 starting in either the 5' or 3' region were generated from pRB309 (see reference 41 for details), and mapping experiments were carried out as described previously (41 Enzyme assays. For hexokinase and invertase assays, cells were grown in medium containing 5% glucose, fructose, or mannose and harvested in the mid-exponential phase (optical density at 600 nm of 1.0 to 2.0). Invertase activity was measured as described by Goldstein and Lampen (30) on whole cells collected from mid-exponential-phase cultures. Hexokinase activity was assayed on crude extracts from mid-exponential-phase cells essentially as described previously (10), with slight modifications (46) . Protein concentration was determined by the method of Lowry et al. (45) .
Western blots (immunoblots). To screen for full-length inactive mutant proteins, yeast cells containing plasmids carrying hxk2 mutations incapable of supporting growth on fructose were grown overnight in medium selecting for the plasmid and harvested. The cells were boiled in sodium dodecyl sulfate-containing protein gel sample buffer before lysis with glass bead beating. The crude extracts were used in Western blot (15) analysis with rabbit antihexokinase antiserum. RESULTS 
AND DISCUSSION
The idea behind our approach to the study of hexokinase II is to obtain mutants with interesting phenotypes without making any prior assumptions about the amino acid residues responsible for hexokinase II function, whether catalytic in glucose phosphorylation or regulatory in glucose repression. Plasmid-borne copies of the HXK2 gene were mutated at random, and the DNA pools from the mutagenesis were used to transform yeast cells. The yeast transformants were screened for interesting phenotypes on a range of carbon sources and under several repressing conditions. The locations of the mutations were determined by fine-structure mapping, and many of the mutants were sequenced. Additional phenotypic analyses were performed to further characterize the mutants, and an attempt was made to understand the properties of the mutants in relation to the positions of the altered amino acid residues in the crystal structure.
Mutagenesis. For the purpose of localized mutagenesis of the HXK2 gene and for the convenience of later molecular manipulations, we chose to mutagenize a HXK2 clone. The yeast centromere plasmids pRB312 and pRB313 were mutagenized as described in Materials and Methods. A total of 85,000 independent E. coli transformants with the mutagenized pRB312 were obtained by selection for ampicillin resistance; the transformants were combined into 32 pools of 500 to 3,500 transformants, and DNA was isolated from cultures of these pools. The mutation frequency was estimated as described in Materials and Methods. The frequency of Uratransformants was 2 to 3% among total E. coli transformants of the mutagenized plasmid. Assuming that the distribution of mutations is uniform throughout the plasmid, we estimate the mutation frequency for HXK2 to be about 5%, because the HXK2 gene is twice as large as URA3.
Both mutagenesis methods used produced, among the 35 mutants ultimately sequenced, 30 single changes, 4 double mutants, and 1 triple mutant. Of the mutations generated in an E. coli mutD strain, 12 are transitions and 7 are transversions, a nonspecificity consistent with previous observations (18, 19, 26) . Among the mutations generated by the misincorporation method, two-thirds are single-base changes and one-third contain two or more base changes per allele.
Screening for mutant phenotypes. Yeast cells transformed with mutagenized pRB313 or pRB312 were screened for various phenotypes. One screening method was for the loss or decrease of hexokinase catalytic activity. In cells of the hxkl hxk2 null background, the only hexokinase is encoded by the plasmid; sufficient reduction of the plasmid-encoded hexokinase activity due to a mutation can lead to a deficiency in fructose fermentation, which requires the activity of hexokinase. In the first experiment, mutagenized pRB313 DNAs isolated from independent cultures of an E. coli mutD strain were used to transform yeast strain DBY2052, and the transformants were replica plated to fructose plates. Those transformants that grew as poorly on fructose as did the double-null hxkl hxk2 mutant were picked as mutants; 18,000 transformants were screened, and eight mutant candidates were identified. The same type of screen was performed by using pRB312 DNA mutagenized by misincorporation, and nine mutant candidates were identified when 1,700 transformants of DBY2192 were screened.
To obtain mutants that had defects in glucose repression but still retained high levels of hexokinase activity, transformants of DBY2052 with pRB313 DNA were pooled, and mutants were identified by using medium containing 2% raffinose and 0.02% 2-deoxyglucose. After a 1-week incubation at 30°C, colonies were picked as mutant candidates. The mutant candidates were then rechecked for growth phenotype on fructose. From the screen of 23,000 (18,000 from the procedure described above plus 5,000 more) transformants, The mutations were mapped by using a simple and rapid method based on homologous recombination between transforming plasmid fragments in yeast cells (41) . The results from many transformations with plasmids containing the point mutants and deletion fragments were used to generate a fine-structure map of the HXK2 gene directly in yeast cells similar to the maps in procaryotes (Fig. 4) (52) ; this may explain, at least in part, why the hxkl mutation has no effect, whereas in minimal medium the hxk2 mutation reduces the growth rate as much as do both mutations.
A subset of the point mutants was examined quantitatively with respect to growth on glucose. These cells have the chromosomal null mutations in both hexokinase genes and carry plasmids expressing mutant hexokinase II. The mutants exhibited a range of doubling times on glucose and various levels of growth on fructose (Table 3) . Furthermore, the mutants that failed to grow on fructose plates also had longer doubling times on glucose, whereas those that grew fairly well on fructose had doubling times on glucose close to that of wild type. The results suggest that the hexokinase II defects affect catalytic activity with either glucose or fructose as the substrate.
Invertase activity of hxk2 point mutants. Invertase activity was measured for several hxk2 point mutants to determine the extent of glucose repression. Invertase is a good indicator of glucose repression because invertase production is normally repressed several hundredfold in the presence of glucose and other repressing substrates and because the enzyme can be easily assayed. The mutants that failed to grow on fructose had high levels of invertase activity; those with short doubling times on glucose grew relatively well on fructose and had low levels of invertase (Table 3 ). The behavior of the mutants suggested an inverse correlation between hexokinase II catalytic activity and the level of glucose repression. The correlation is examined more thoroughly in the accompanying paper (46) .
Hexokinase activity of hxk2 point mutants. In the chromosomally double null strains used in this study, the plasmidborne hexokinase II growth on fructose at 37°C than at 26°C (Table 4) ; they had shown partial growth on fructose at 30°C in the original screen. The mutants that exhibited reduced growth on fructose at 37°C showed similar extents of growth on mannose at either 26 or 37°C (data not shown), which means that these mutants have a differential temperature-sensitive growth phenotype for the substrates fructose and mannose.
The mutants that were temperature sensitive for growth on fructose were analyzed in vitro. Crude extracts made from these mutants generally had low levels of hexokinase activity (Table 4 ). In addition, hexokinase activity in many mutants was lower in crude extracts from the cells grown on glucose at 37°C than at 26°C, whereas extract from the wild-type cells showed only a slight drop in activity.
The largest class of mutants were the totally inactive ones, as judged by their failure to grow on fructose. Many of these mutants probably resulted from frameshift or nonsense mutations or they may produce proteins that are sensitive to protease degradation. Nevertheless, we reasoned that a subset of these mutants may produce proteins that are catalytically inactive but still relatively stable; among these there should be mutations that specifically alter amino acid residues responsible for catalysis without changing the overall structure of the protein. Therefore, the members of this class of mutants were examined for the production of intact yet inactive hexokinase II protein. Western blot experiments were performed on about 140 mutants that grew as poorly on fructose as did the double-null mutant. Only six mutants were found to contain intact protein by this assay; most mutants had no detectable intact hexokinase II activity (Fig.  5) .
Sequences of the mutations. Many of the mutations identified during the phenotypic screens were sequenced after they were mapped (5). We were interested in finding out the positions of the three-dimensional structure, as determined by X-ray crystallography, of the amino acid residues altered in the mutants temperature sensitive for growth on fructose. Sequence analysis of these mutants (Table 4) showed that many of the changes were in the middle of an a helix or B sheet. In addition, some mutations changed residues (e.g., Gln-193 and Ser-305) to prolines. Examination of the threedimensional structure of hexokinase II indicated that almost all of these mutations altered residues that are relatively far from the sugar-binding site. Many of the amino acid residues that were altered by the fructose-temperature-sensitive mutations were seen to be partially or completely buried inside the protein. Studies with lambda repressor (35, 36, 54) and T4 lysozyme (1) (2) (3) (31) (32) (33) indicate that alterations in the interior of the protein tend to cause thermal instability, whereas mutations on the protein surface have much less effect on stability. In addition, most of these mutant hexokinase II proteins are found in the cell at much lower levels than is the wild-type enzyme. Studies of the Cro protein (Table 5) . It could also allow growth on mannose and provide glucose repression if it were produced at a much higher level from a pSI4 derivative. The hexokinase activity from a strain with such a pSI4 derivative, using fructose as a substrate, was about the same as from cells with a centromere plasmid carrying a HXK2 allele. We suggest that the ATG is necessary for efficient expression but not for encoding catalytic activity of hexokinase II.
Structure-function correlations. The six mutant isolates identified by Western blot analysis as producing full-length hexokinase II proteins incapable of supporting growth on fructose were analyzed by DNA sequencing after they had been mapped. They altered three different amino acid residues (Table 6 ): Gly-89-*Asp (hxk2-298), Asn-237--"His (hxk2-183, -289, and -290), and Ser-306--Phe (hxk2-049 and -517). In addition to these three mutations uncovered by Western blot analysis, sequence analysis of other null-like mutations, which were found by screening on fructose plates, identified three other missense mutations (Table 6) : Thr-90-Ile (hxk2-098) and Gly-235--*Cys (hxk2-070) and a mutation (hxk2-065) changing two residues, Gln-376-"Glu and Ile-381-3Met. Among the altered amino acid residues, Gly-235 and Asn-237 have been proposed to different levels of resolution or to real differences in the structures of these two isoenzymes or it may represent aspects of the mechanism of sugar binding as yet not understood. Nevertheless, regardless of the role of Gly-235 and Asn-237 in hydrogen bonding to a sugar substrate, the substitution of glycine with cysteine and that of asparagine with histidine could disrupt sugar binding simply because of the positions of the residues. The residue Gly-89 lies at the end of an antiparallel beta loop in the domain that moves during the conformation change upon glucose binding. The fact that the mutation of this glycine to aspartate renders the enzyme inactive implies that the beta loop may be involved in the catalysis after the conformation change. The substitution of Phe for Ser-306 may affect activity by disrupting the active-site structure with the introduction of a large side chain. Finally, the substitutions Gln-376 to Glu and Ile-381 to Met may represent leads to the mechanisms of the function of the protein that are not obvious from the crystallographic information. On the other hand, the possibility remains that these mutations affect the overall structure of the protein rather than the active site.
Conclusion. Our analysis by random mutagenesis has resulted in the inference of important function for two amino acid residues of hexokinase II that plausibly might form hydrogen bonds with sugar substrates and four more residues that do not. This result alone seems to us to justify the effort required to undertake the random mutagenesis strategy, for it is unlikely that Ser-306, which when altered to Phe leads to inactive protein, would otherwise have been implicated specifically in the function of the protein. The ambiguity concerning Asn-210 and Asp-211 suggests a site-directed mutagenesis experiment that could, if the alterations of these residues failed to affect function, deny their role in substrate binding or catalysis. In a more general way, these results might be paradigmatic for the relative roles of random and site-directed mutagenesis in analysis of protein structure-function relationships; the random approach has the power to point to residues important for function, whereas the site-directed approach excels at experimental tests of preexisting hypotheses.
